175 related articles for article (PubMed ID: 11235727)
21. Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases.
Tardy-Poncet B; Wolf M; Lasne D; Bauters A; Ffrench P; Elalamy I; Tardy B
Intensive Care Med; 2009 Aug; 35(8):1449-53. PubMed ID: 19350215
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
23. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
[TBL] [Abstract][Full Text] [Related]
24. Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost.
Antoniou T; Kapetanakis EI; Theodoraki K; Rellia P; Thanopoulos A; Kotiou M; Zarkalis D; Alivizatos P
Heart Surg Forum; 2002; 5(4):354-7. PubMed ID: 12538117
[TBL] [Abstract][Full Text] [Related]
25. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia].
Salmi L; Elalamy I; Leroy-Matheron C; Houel R; Thébert D; Duvaldestin P
Ann Fr Anesth Reanim; 2006; 25(11-12):1144-8. PubMed ID: 17174213
[TBL] [Abstract][Full Text] [Related]
26. Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
Zöhrer' B; Zenz W; Rettenbacher A; Covi P; Kurnik K; Kroll H; Grubbauer HM; Muntean W
Acta Paediatr; 2001 Jul; 90(7):765-71. PubMed ID: 11519979
[TBL] [Abstract][Full Text] [Related]
27. Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease.
Macchi L; Sarfati R; Guicheteau M; Chamlian V; Pourrat O; Gruel Y; Magnin G; Brizard A; Boinot C
Clin Appl Thromb Hemost; 2000 Oct; 6(4):187-9. PubMed ID: 11030522
[TBL] [Abstract][Full Text] [Related]
28. The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
Hertle DN; Hähnel S; Richter GM; Unterberg A; Sakowitz OW; Kiening KL
Br J Neurosurg; 2011 Feb; 25(1):117-9. PubMed ID: 20707682
[TBL] [Abstract][Full Text] [Related]
29. Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.
Lindhoff-Last E; Betz C; Bauersachs R
Clin Appl Thromb Hemost; 2001 Oct; 7(4):300-4. PubMed ID: 11697713
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.
Wan C; Warner M; De Varennes B; Ergina P; Cecere R; Lachapelle K
Ann Thorac Surg; 2006 Jul; 82(1):21-6. PubMed ID: 16798180
[TBL] [Abstract][Full Text] [Related]
31. [Heparin-induced thrombocytopenia--a serious complication within the scope of heparin therapy. Follow-up of 7 trauma surgery patients].
Kuhn B
Unfallchirurg; 1997 Aug; 100(8):646-51. PubMed ID: 9381213
[TBL] [Abstract][Full Text] [Related]
32. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
Grocott HP; Root J; Berkowitz SD; deBruijn N; Landolfo K
J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):875-7. PubMed ID: 9412888
[No Abstract] [Full Text] [Related]
33. [Heparin-induced type II thrombocytopenia within the scope of high dose chemotherapy with subsequent stem cell rescue].
Sauer M; Gruhn B; Fuchs D; Altermann W; Zintl F
Klin Padiatr; 1998; 210(3):102-5. PubMed ID: 9629542
[TBL] [Abstract][Full Text] [Related]
34. Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
Pamboukian SV; Ignaszewski AP; Ross HJ
J Heart Lung Transplant; 2000 Aug; 19(8):810-4. PubMed ID: 10967277
[TBL] [Abstract][Full Text] [Related]
35. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.
Farner B; Eichler P; Kroll H; Greinacher A
Thromb Haemost; 2001 Jun; 85(6):950-7. PubMed ID: 11434701
[TBL] [Abstract][Full Text] [Related]
36. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Saxon BR; Black MD; Edgell D; Noel D; Leaker MT
Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
[TBL] [Abstract][Full Text] [Related]
37. [Successful use of a heparinoid (danaparoid sodium) for heparin-induced thrombocytopenia type II in aortic valve reoperation].
Scheffler E; Aulmann M; Remppis A; Ziegler R; Martin E; Fleischer F; Nawroth P
Z Kardiol; 1995 Jul; 84(7):565-8. PubMed ID: 7676727
[TBL] [Abstract][Full Text] [Related]
38. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
[TBL] [Abstract][Full Text] [Related]
39. Novel Use of Cangrelor With Heparin During Cardiopulmonary Bypass in Patients With Heparin-Induced Thrombocytopenia Who Require Cardiovascular Surgery: A Case Series.
Gernhofer YK; Banks DA; Golts E; Pretorius V
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):763-769. PubMed ID: 31610233
[TBL] [Abstract][Full Text] [Related]
40. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
Pouplard C; Regina S; May MA; Gruel Y
Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]